ENTRY       K08288                      KO
NAME        PRKCSH
DEFINITION  protein kinase C substrate 80K-H
PATHWAY     ko04141  Protein processing in endoplasmic reticulum
DISEASE     H00545  Polycystic liver disease
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Genetic Information Processing
              Folding, sorting and degradation
               04141 Protein processing in endoplasmic reticulum
                K08288  PRKCSH; protein kinase C substrate 80K-H
            Lectins [BR:ko04091]
             P-type lectins
              K08288  PRKCSH; protein kinase C substrate 80K-H
GENES       HSA: 5589(PRKCSH)
            PTR: 455731(PRKCSH)
            PPS: 100981178(PRKCSH)
            GGO: 101147116(PRKCSH)
            PON: 100453773
            MCC: 714650(PRKCSH)
            MCF: 102139849(PRKCSH)
            MMU: 19089(Prkcsh)
            RNO: 300445(Prkcsh)
            CGE: 100753910(Prkcsh)
            HGL: 101712131(Prkcsh)
            TUP: 102470093(PRKCSH)
            CFA: 484941(PRKCSH)
            AML: 100483511
            FCA: 101081869(PRKCSH)
            PTG: 102972264(PRKCSH)
            BTA: 338067(PRKCSH)
            BOM: 102288163(PRKCSH)
            PHD: 102339755(PRKCSH)
            CHX: 102168717(PRKCSH)
            SSC: 100516540(PRKCSH)
            CFR: 102520921(PRKCSH)
            BACU: 103002509(PRKCSH)
            LVE: 103068459(PRKCSH)
            ECB: 100056942(PRKCSH)
            MYB: 102240197(PRKCSH)
            MYD: 102762171(PRKCSH)
            PALE: 102886210(PRKCSH)
            MDO: 100010762(PRKCSH)
            SHR: 100919308(PRKCSH)
            OAA: 100079714(PRKCSH)
            ASN: 102379677(PRKCSH)
            AMJ: 102559389(PRKCSH)
            PSS: 102453662(PRKCSH)
            CMY: 102939781(PRKCSH)
            ACS: 100552971
            PBI: 103060357(PRKCSH)
            XLA: 444614 447013(prkcsh)
            XTR: 394983(prkcsh)
            DRE: 394028(prkcsh)
            TRU: 101061409
            MZE: 101468404 101471565
            OLA: 101159748 101164594
            XMA: 102231987
            LCM: 102346533(PRKCSH) 102364562
            CMK: 103171680(prkcsh)
            BFO: BRAFLDRAFT_126344
            SPU: 584203
            DME: Dmel_CG6453
            DPO: Dpse_GA19606
            DAN: Dana_GF15099
            DER: Dere_GG21740
            DPE: Dper_GL15951
            DSE: Dsec_GM17123
            DSI: Dsim_GD21864
            DWI: Dwil_GK24827
            DYA: Dyak_GE13129
            DGR: Dgri_GH10155
            DMO: Dmoj_GI22410
            DVI: Dvir_GJ20305
            AGA: AgaP_AGAP004609
            AAG: AaeL_AAEL012394
            CQU: CpipJ_CPIJ009731
            AME: 552747(GB18192)
            NVI: 100115591
            TCA: 663522
            BMOR: 101746261
            API: 100161041 100573036
            PHU: Phum_PHUM380960
            ISC: IscW_ISCW006355 IscW_ISCW013550
            CEL: CELE_ZK1307.8
            CBR: CBG00964
            BMY: Bm1_42055
            LOA: LOAG_02299
            TSP: Tsp_00413
            SMM: Smp_131400
            NVE: NEMVE_v1g245724
            HMG: 100203932 100211631
            TAD: TRIADDRAFT_64136
            AQU: 100634209 100636558
            ATH: AT5G56360(PSL4)
            ALY: ARALYDRAFT_918782
            CRB: CARUB_v10028007mg
            EUS: EUTSA_v10012928mg
            CIT: 102617815 102627402
            CIC: CICLE_v10014526mg CICLE_v10016674mg
            TCC: TCM_003549 TCM_025974 TCM_038627
            GMX: 100306278 100783506 100807083 100811132
            PVU: PHAVU_002G101100g PHAVU_011G116600g
            MTR: MTR_096s0015 MTR_4g079430 MTR_4g083360
            CAM: 101512556
            FVE: 101291350 101310878
            PPER: PRUPE_ppa002821mg PRUPE_ppa020312mg
            CSV: 101205514 101221877 101230375 101230880
            RCU: RCOM_0342850 RCOM_0554380 RCOM_1122020
            POP: POPTR_0001s03900g(POPTRDRAFT_177760) POPTR_0003s20810g(POPTRDRAFT_555175) POPTR_0013s05680g(POPTRDRAFT_571230) POPTR_0013s12780g POPTR_0019s12190g(POPTRDRAFT_914334)
            VVI: 100255312 100264427
            SLY: 101244125 101257751
            SOT: 102587999 102601829
            OSA: 4324264
            DOSA: Os01t0276800-01(Os01g0276800)
            OBR: 102704856
            BDI: 100826220 100839821
            ZMA: 100279534 100279808(pco088319)
            SITA: 101777457 101778959
            ATR: s00021p00184700(AMTR_s00021p00184700)
            SMO: SELMODRAFT_162920
            PPP: PHYPADRAFT_159327 PHYPADRAFT_62870
            CRE: CHLREDRAFT_105079
            VCN: VOLCADRAFT_120319
            OLU: OSTLU_7884
            MIS: MICPUN_89045
            MPP: MICPUCDRAFT_7713
            BPG: Bathy15g00210
            CSL: COCSUDRAFT_48116
            CVR: CHLNCDRAFT_141729
            CME: CYME_CMN288C
            GSL: Gasu_08690
            CCP: CHC_T00000021001
            AGO: AGOS_AGR178W
            ERC: Ecym_4136
            KLA: KLLA0F13178g
            LTH: KLTH0E10054g
            PPA: PAS_chr3_0179
            VPO: Kpol_529p7
            ZRO: ZYRO0A09548g
            NCS: NCAS_0B02800(NCAS0B02800)
            NDI: NDAI_0C04900(NDAI0C04900)
            TPF: TPHA_0C02100(TPHA0C02100)
            TBL: TBLA_0H00610(TBLA0H00610)
            TDL: TDEL_0B02050(TDEL0B02050)
            KAF: KAFR_0E02590(KAFR0E02590)
            DHA: DEHA2E17402g
            PIC: PICST_48346
            PGU: PGUG_03253
            LEL: LELG_00229
            SPAA: SPAPADRAFT_133564
            CAL: CaO19.10796 CaO19.3286
            CTP: CTRG_01013
            CDU: CD36_25790
            COT: CORT_0A02550
            CTEN: CANTEDRAFT_110157
            YLI: YALI0E26895g
            CLU: CLUG_03050
            SMP: SMAC_03320
            PAN: PODANSg0987
            TTT: THITE_2110681
            MTM: MYCTH_2307289
            CTHR: CTHT_0046400
            MGR: MGG_16417
            TMN: UCRPA7_6759
            FGR: FG08126.1
            NHE: NECHADRAFT_66980
            TRE: TRIREDRAFT_77539
            MAW: MAC_01553
            MAJ: MAA_02390
            CMT: CCM_04953
            VAL: VDBG_09648
            ELA: UCREL1_5010
            SSL: SS1G_12945
            BFU: BC1G_11887
            MBE: MBM_05944
            ANI: AN5697.2
            AFM: AFUA_7G04110
            AOR: AOR_1_166174(AO090005000093)
            ANG: ANI_1_82114(An13g00620)
            AFV: AFLA_073350
            ACT: ACLA_005810
            NFI: NFIA_025080
            PCS: Pc21g04650
            CIM: CIMG_04388
            CPW: CPC735_073500
            PBL: PAAG_01390
            URE: UREG_01625
            ABE: ARB_05809
            TVE: TRV_04537
            AJE: HCAG_08110
            PNO: SNOG_02157
            PTE: PTT_10447
            BZE: COCCADRAFT_38823
            ZTR: MYCGRDRAFT_69270
            PFJ: MYCFIDRAFT_85357
            BCOM: BAUCODRAFT_270580
            TML: GSTUM_00000285001
            SPO: SPCC825.02
            CNE: CNA04410
            CNB: CNBA4240
            CGI: CGB_A4550C
            PPL: POSPLDRAFT_38195
            LBC: LACBIDRAFT_191258
            MPR: MPER_10676
            CCI: CC1G_08200
            SCM: SCHCODRAFT_63868
            MGL: MGL_3008
            MBR: MONBRDRAFT_31090
            DDI: DDB_G0271120
            DPP: DICPUDRAFT_57640
            DFA: DFA_09012
            EHI: EHI_135420
            EDI: EDI_271610
            ACAN: ACA1_000840
            PTI: PHATR_54169
            PIF: PITG_06992 PITG_10020 PITG_14939
            NGD: NGA_2033900
            EHX: EMIHUDRAFT_207494 EMIHUDRAFT_463291 EMIHUDRAFT_469871 EMIHUDRAFT_469954
            GTT: GUITHDRAFT_100786
            TBR: Tb927.7.940(Tb07.29K4.250)
            TCR: 508215.9
            LBZ: LBRM_26_1010
            NGR: NAEGRDRAFT_71661
REFERENCE   PMID:10929008
  AUTHORS   Pelletier MF, Marcil A, Sevigny G, Jakob CA, Tessier DC, Chevet E, Menard R, Bergeron JJ, Thomas DY
  TITLE     The heterodimeric structure of glucosidase II is required for its activity, solubility, and localization in vivo.
  JOURNAL   Glycobiology 10:815-27 (2000)
///
